Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension

Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension

Aim. To study candesartan effectiveness and tolerability in essential arterial hypertension (ГАН) and AH associated with chronic renal disease.Material and methods. This 12-week open, controlled study included 14 patients (mean age 43,4±16 years) with diagnosed ГАН (n=9) or secondary AH of renal eti...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. M. Chikhladze, O. A. Sivakova, E. V. Blinova, T. A. Sakhnova, I. P. Kolos, G. N. Litonova, I. E. Chazova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension candesartan organo-protection microalbuminuria
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1671
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trandolapril and verapamil SR combination effectiveness in arterial hypertension patients
by: N. M. Chikhladze, et al.
Published: (2007-04-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
by: N. M. Chikhladze, et al.
Published: (1970-01-01)

Renal pathology features in arterial hypertension patients with and without metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

Renal hemodynamics disturbances and microalbuminuria in young patients with arterial hypertension
by: I. G. Fomina, et al.
Published: (2005-06-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS
by: P. K. Karnakova, et al.
Published: (2021-11-01)

Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01)

DYNAMICS OF PARAMETERS OF PROINFLAMMATORY ACTIVATION IN PATIENTS WITH HYPERTENSION UNDER INFLUENCE OF CANDESARTAN THERAPY
by: V. A. Vizir, et al.
Published: (2014-05-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

Comparison of various renal function assessment methods in patients with arterial hypertension
by: S. V. Villevalde, et al.
Published: (2008-08-01)

Candesartan: A pharmaceutical product as effective corrosion inhibitor for aluminum in acidic solution
by: Abdel Aziz Fouda, et al.
Published: (2021-09-01)

Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01)

Optimization and validation of UPLC method for dapagliflozin and candesartan cilexetil in an on-demand formulation: Analytical quality by design approach
by: Elzayat Ehab M., et al.
Published: (2025-07-01)

Methods of renal function assessment in arterial hypertension: the clinical value and practical implementation
by: Zh. D. Kobalava, et al.
Published: (2009-12-01)

GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Technological approaches to improve the bioavailability of the poor soluble substance Candesartan Cilexetil in mini-tablets
by: K. M. Tserkovnaya, et al.
Published: (2025-03-01)

Myocardial functional status in patients with arterial hypertension and hyperaldosteronism: orthogonal electrocardiography assessment
by: Kh. F. Samedova, et al.
Published: (2006-04-01)

Arterial hypertension, cardiovascular remodeling and plasma level of osteopontin in patients with end-stage kidney disease on hemodialysis
by: V. A. Vizir, et al.
Published: (2014-12-01)

Angioprotection role in arterial hypertension treatment: focus on olmesartan
by: D. V. Nebieridze, et al.
Published: (2012-10-01)

New perspectives of renoprotection in patients with Type 2 diabetes mellitus and arterial hypertension
by: A. S. Ametov, et al.
Published: (2004-12-01)

Prevalence of Microalbuminuria Among Type 2 Diabetic and Hypertensive Patients Attending the University of Calabar Teaching Hospital, Calabar, Nigeria.
by: Bassey, I.E. *, Akpama, A.E.O. , Nehemiah, E.D. , Efobi, H.A. , Mba, C. , Udoh, A.E.
Published: (2019-03-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01)

Prevalence of hypertension and microalbuminuria in children of hypertensive and non-hypertensive parents in Calabar, Nigeria: A comparative study
by: Akpakpan IV, et al.
Published: (2025-04-01)

MICROALBUMINURIA AS A FORECAST FACTOR FOR CARDIO-VASCULAR COMPLICATIONS AND A MARKER OF THERAPY EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva, et al.
Published: (2016-01-01)

Sustained-release calcium antagonist in patients over 60 years with isolated and systolo-diastolic arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2008-12-01)

Exploring Candesartan, an angiotensin II receptor antagonist, as a novel inhibitor of NLRP3 inflammasome: alleviating inflammation in Neisseria gonorrhoeae infection
by: Wen-Yu Lin, et al.
Published: (2024-11-01)

Comparative effects of candesartan and losartan on mesangial expansion and glomerular volume in diabetes rat model receiving rosmarinic acid therapy
by: Nur Samsu, et al.
Published: (2024-03-01)

Organo-protective effects of a calcium antagonist nifedipine SR in elderly patients with isolated and systolo-diastolic arterial hypertension
by: V. E. Oleynikov, et al.
Published: (1970-01-01)

Description of cardiovascular remodeling parameters and osteopontin plasma level in dynamics of the candesartan therapy in patients with chronic kidney disease on the stage before dialysis
by: V. A. Vizir, et al.
Published: (2015-04-01)

RESISTANT ARTERIAL HYPERTENSION
by: T. E. Esaulova, et al.
Published: (2018-09-01)

Developing approaches to treating arterial hypertension in regard to possible pathways of angiotensin II synthesis
by: N. M. Chikhladze, et al.
Published: (2006-04-01)

The renal function in men with hypertension in conditions of purine and carbohydrate metabolism disorders
by: O. V. Dudko, et al.
Published: (2022-11-01)

Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter
by: Ya. V. Zemlyaniy
Published: (2014-04-01)

EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva
Published: (2016-01-01)

From In Vivo Predictive Dissolution to Virtual Bioequivalence: A GastroPlus<sup>®</sup>-Driven Framework for Generic Candesartan Cilexetil Tablets
by: Hao Ruan, et al.
Published: (2025-04-01)

Essential arterial hypertension in women, or female arterial hypertension?
by: V. I. Podzolkov, et al.
Published: (2012-02-01)

KIDNEY AND HEART INVOLVEMENT IN ARTERIAL HYPERTENSION: EVOLUTION OF VIEW FROM R. BRIGHT AND E.M. TAREEV TO PRESENT DAYS
by: V. I. Podzolkov, et al.
Published: (2010-06-01)

Microalbuminuria as an indicator for LVH severity in patients with primary hypertension
by: Govind Tripathi, et al.
Published: (2025-03-01)

RENAL DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME AND ARTERIAL HYPERTENSION
by: G. Kh. Sharipova, et al.
Published: (2009-06-01)